Hansson, Johan
Karolinska University Hospital · Karolinska Institutet
4 papers on CoChatORCID 0000-0002-2618-3779
Most cited papers
- Verified
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
Rozeman, E. A., Menzies, A. M., van Akkooi, A. C. J., Adhikari, C., Bierman, C., van de Wiel, B. A., Scolyer, R. A., Krijgsman, O., Sikorska, K., Eriksson, H., et al. (2019) · The Lancet Oncology
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 537
- Verified
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
Hamid, O., Schmidt, H., Nissan, A., Ridolfi, L., Aamdal, S., Hansson, J., Guida, M., Hyams, D. M., Gómez, H., Bastholt, L., et al. (2011) · Journal of Translational Medicine
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 534
- Verified
Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
de Coaña, Y. P., Wolodarski, M., Poschke, I., Yoshimoto, Y., Yang, Y., Nyström, M., Edbäck, U., Brage, S. E., Lundqvist, A., Masucci, G. V., et al. (2017) · Oncotarget
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 139
- Verified
Use of snus and risk for cardiovascular disease: results from the Swedish Twin Registry
Hansson, J., Pedersen, N. L., Galanti, M. R., Andersson, T., Ahlbom, A., Hallqvist, J., & Magnusson, C. (2009) · Journal of Internal Medicine
Smoking Behavior and CessationCardiovascular Health and Risk Factors
Cited by 54
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free